Synthesis and in-vitro antioxidant activity of substituted pyridinyl 1, 3, 4 oxadiazole derivatives

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 1, Issue 4, 2010, Pages 1083-1090

  Vijey Aanandhi, M ^a   Mansoori, Mohammed Hashim ^a   Shanmugapriya, S ^a   George, Shiny ^a   Shanmugasundaram, P ^a  

^a VELS INSTITUTE OF SCIENCE   (India)

Author keywords

Nicotinic acid; Oxadiazole and antioxidant activity; Schiff base

Indexed keywords

1 [(5 PYRIDINE 3 YL) 2 4 TOLYL 1,3,4 OXADIAZOLE 3(2H) YL]ETHANONE; 1 [2 (2 CHLOROPHENYL) 5 (PYRIDINE 3 YL) 1,3,4 OXADIAZOLE 3(2H) YL]ETHANONE; 1 [2 (2 NITROPHENYL) 5 (PYRIDINE 3 YL) 1,3,4 OXADIAZOLE 3(2H) YL]ETHANONE; 1 [2 (3 CHLORO 4 NITROPHENYL) 5 (PYRIDINE 3 YL) 1,3,4 OXADIAZOLE 3(2H) YL]ETHANONE; 1 [2 (3 NITROPHENYL) 5 (PYRIDINE 3 YL) 1,3,4 OXADIAZOLE 3(2H) YL]ETHANONE; 1 [2 (3,4 DIMETHOXYPHENYL) 5 (PYRIDINE 3 YL) 1,3,4 OXADIAZOLE 3(2H) YL]ETHANONE; 1 [2 (4 DIMETHYLAMINO)PHENYL] 5 (PYRIDINE 3 YL) 1,3,4 OXADIAZOLE 3(2H) YL ETHANONE; 1 [2 (4 HYDROXY 3 METHOXYPHENYL) 5 (PYRIDINE 3 YL) 1,3,4 OXADIAZOLE 3(2H) YL]ETHANONE; 1 [2 (4 METHOXYPHENYL) 5 (PYRIDINE 3 YL) 1,3,4 OXADIAZOLE 3(2H) YL]ETHANONE; 1 [2 PHENYL 5 (PYRIDIN 3 YL) 1,3,4 OXADIAZOLE 3(2H) YL]ETHANONE; 1,3,4 OXADIAZOLE DERIVATIVE; NICOTINIC ACID; NITRIC OXIDE; PYRIDINYL 1,3,4 OXADIAZOLE DERIVATIVE; SCHIFF BASE; UNCLASSIFIED DRUG;

ACETYLATION; ANTIOXIDANT ACTIVITY; ARTICLE; CHLORINATION; CRYSTALLIZATION; DRUG SCREENING; DRUG SYNTHESIS; IC 50; IN VITRO STUDY; MASS SPECTROMETRY; MELTING POINT; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 79952526638     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Yeong Woo Jo, Weon Bin Im, Jae Keol Rhee, Mi Ja Shim, Won Bae Kim and Eung Chil Choi. Bioorganic Med Chem 2004; 12(22): 5909-5915.
2. Gabriel Navarrete-Vazquez, Gloria Mari{dotless}a Molina-Salinas, Zetel Vahi Duarte-Fajardo, Javier Vargas-Villarreal, Samuel Estrada-Soto, Bioorganic Med Chem 2007; 15 (16): 5502-5508.
3. Kalia R, Rao CM, Kutty NG. Arzneimittel-Forschung-Drug Research 2007; 57(9): 616-22.
4. Shanthaveerappa Boovanahalli K, Xuejun Jin, Yinglan Jin, Jin Hwan Kim, Nguyen Tien Dat, Young Soo Hong, Jeong Hyung Lee, Sang Hum Jung, Kyeong Lee, Jung Joon Lee. Bioorg Med Chem Lett 2007; 17: 6305-10.
5. Pandey VK, Gupta VD, Mrinalini Upadhyay, Mridula Upadhyay, Singh VK, Meenal Tandon. Ind J Chem 2005; 44B: 158-62.
6. Mrunmayee Toraskar P, Vithal Kulkarni M, Vilasrao Kadam. Int J Chem Tech Res 2009; 3: 696-701.
7. Chrysoula Spanou, Stella Manta, Dimitri Komiotis, Albiona Dervishi and Demetrios Kouretas. Int J Mol Sci 2009; 8: 695-704.
8. Gugila Sandhyarani, Kantham Srinivas, Kusuma Praveen Kumar. Int J Biopharm 2010; 1: 14-19.
9. Desai NC, Bhavsar AM, Shah MD, Anil Saxena K. Indian J Chem 2008; 47B: 579-589.
10. Asif Hussain, Mohammed Ajmal. Acta Pharm 2009; 59: 223-233.
11. Padmavathi V, Nagi Reddy S, Dinneswara Reddy G, Padmaja A. European J Med Chem 2010; 45 (9): 4246-4251.
12. Tagashira M, Ohtake Y. Planta Med 1998; 64: 555-558.
13. Garrat DC. The Quantitative Analysis of Drugs, Japan, Chapman and Hall, 1964, 456.